RxDoctor Payments Data

Nisha Cyriac

Family · Joliet, ILNPI 1689238420

Payments from drug & device makers

$581in general payments, 2019–2025

Across 24 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pinnacle Biologics, Inc$116
  • AbbVie$106
  • Takeda Pharmaceuticals U.S.A., Inc.$104
  • Ardelyx, Inc.$94
  • Phathom Pharmaceuticals, Inc.$57
  • Johnson & Johnson$50
  • plus $55 from 3 others

What the payments were for

  • Food & beverage$581100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$581 in reported general payments places this provider in the 60th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$3,366
Medicare patients
20
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase23$130,114
LinzessLinaclotide63$69,037
TrulancePlecanatide14$10,316
Omeprazole514$7,803
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates114$7,368
Dexlansoprazole DrDexlansoprazole23$6,404
Pantoprazole Sodium296$5,496
Esomeprazole Magnesium65$4,572
Azathioprine17$2,560
CholestyramineCholestyramine (With Sugar)22$2,114
Famotidine71$1,851
Rabeprazole Sodium28$1,375
Ondansetron OdtOndansetron29$452
Sertraline Hcl11$364
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl14$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Aimmune Therapeutics, Inc.Zenpep$21$130,11423 claims
AbbVieLinzess$106$69,03763 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,941 family providers in Illinois.

Other family in Joliet

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →